![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Connect with our experts and industry leaders to uncover strategies to help you achieve more.
What are biosimilars?
Essential steps to help health systems better prepare for disruptions.
By
Date
February 14, 2022
By: McKesson MedSurg Editorial Team
Read time: 5 minutes
There are important differences between biosimilars and biologics. research and studies show that the use of biosimilar drugs can save money for both patients and providers, and increased affordability of biosimilars can have a meaningful impact on the healthcare system.
To dive deeper into the differences, examining the costs and benefits, Derek Burns and Tim Ho, clinical specialists at McKesson, share their insights on biosimilars and discuss their expert knowledge of these new products.
Related Stories
Join us in taking this opportunity to celebrate the contributions of pharmacy technicians, whose training and professionalism support positive outcomes.
McKesson leaders attending a C-Suite dialogue on leveraging ambulatory pharmacy settings.
Explore the value a strategic partnership can bring in helping take your health system pharmacy further to achieve more.
Use this comprehensive library of resources to find important information on what’s changing with 340B and IRA, when, and why it may matter for your health system pharmacy.
Hear part two of LogiPharma’s interview with McKesson Health Systems President Ammie McAsey.
On Women Pharmacist Day, we recognize the unique perspectives and contributions of these critical healthcare professionals.
McKesson Health Systems President Ammie McAsey joins a keynote panel to discuss the growing importance of collaboration across the healthcare ecosystem.
McKesson Health Systems President Ammie McAsey contributes expert insights on how we’re enabling pharmacy to do more for the advancement of patient health.
An interactive experience highlighting key insights for success across 8 domains of specialty pharmacy.